Clicks (CLS)
Johannesburg Exchange · South Africa · prices in ZAC · close of 23 Oct 2026
Key indicators
| Last close | ZAC 21,657.00 |
|---|---|
| 52-week range | 18,366.00 – 38,618.00 |
| Return, 1 month / 3 months | +2.2% / +2.8% |
| Return, 1 year / 3 years | −39.7% / −4.1% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 30.8% |
| Worst drawdown (1 year) | -48.9% |
| Average daily value traded | 36,834.16M ZAC |
| Dividend yield | 4.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Clicks is a South African health and beauty retailer that runs a chain of drugstores and pharmacies across the country. Its stores offer medicines, toiletries, cosmetics, baby care and household products, and many outlets include a pharmacy where customers can collect prescriptions and get health advice. The company serves everyday shoppers through its retail stores and a loyalty programme, and it is based in South Africa, where its outlets are a familiar sight in towns and shopping centres.
Clicks trades under the code CLS on the Johannesburg Exchange in South Africa, with its price quoted in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Clicks (CLS) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 21,657.00 on 23 October 2026.
Its price-based Market X-Ray is 38 out of 100 (a weak price profile), ranking 167 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 39.7% and over the last three months it rose 2.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 12 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -15.1% | ||
| From 52-week high | -42.3% | ||
| Momentum | 29 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 2.8% | ||
| 6-month return | -20.6% | ||
| 12-month return, skipping the last month | -40.9% | ||
| Stability (higher is calmer) | 39 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.9% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 36,834.16M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 4.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −9.8% |
|---|---|
| 1 month | +2.2% |
| 3 months | +2.8% |
| 6 months | −20.6% |
| 1 year | −39.7% |
| 3 years | −4.1% |
| 5 years | −10.7% |
Signals
| 50-day / 200-day average | 21,004.22 / 25,507.59 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 917.29 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Jul 2026 | ZAC 258.0000 |
| 21 Jan 2026 | ZAC 648.0000 |
| 2 Jul 2025 | ZAC 238.0000 |
| 22 Jan 2025 | ZAC 566.0000 |
| 26 Jun 2024 | ZAC 210.0000 |
| 24 Jan 2024 | ZAC 494.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.